As of my last knowledge update in October 2023, "VISTA-IN-3" with the CAS number 2994662-45-0 is not widely recognized in the scientific literature or databases. This may indicate that it is a novel compound, a proprietary substance, or a compound that has not yet been extensively studied or characterized in public resources. Typically, the characteristics of a chemical substance include its molecular formula, structure, physical properties (such as melting point, boiling point, solubility), and potential applications or biological activity. For specific details regarding VISTA-IN-3, including its synthesis, mechanism of action, and any relevant safety data, it would be advisable to consult specialized databases, scientific publications, or proprietary sources that may have more comprehensive information on this compound. If it is a recent development, checking the latest research articles or patent filings could provide further insights.

VISTA-IN-3

2994662-45-0: As of my last knowledge update in October 2023, "VISTA-IN-3" with the CAS number 2994662-45-0 is not widely recognized in the scientific literature or databases. This may indicate that it is a novel compound, a proprietary substance, or a compound that has not yet been extensively studied or characterized in public resources. Typically, the characteristics of a chemical substance include its molecular formula, structure, physical properties (such as melting point, boiling point, solubility), and potential applications or biological activity. For specific details regarding VISTA-IN-3, including its synthesis, mechanism of action, and any relevant safety data, it would be advisable to consult specialized databases, scientific publications, or proprietary sources that may have more comprehensive information on this compound. If it is a recent development, checking the latest research articles or patent filings could provide further insights.

<p>VISTA-IN-3 (Compound A4), a potent small molecule inhibitor of VISTA, exhibits a dissociation constant (K D) of 0.49 μM. This compound effectively induces the release of IFN-γ cytokines and demonstrates synergistic enhancement of anti-cancer activity when combined with PD-L1 antibody [1].</p>

CAS 2994662-45-0

VISTA-IN-3

VISTA-IN-3

Ref: TM-T87620